Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...

Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

A UK-based study develops and validates a five–drug class model that uses routine clinical data to identify optimal ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Metformin is a medication prescribed to help manage type 2 diabetes. Recent research suggests, however, this medication may ...

The federal government announced more than $30 million over four years to pay for diabetes medication and supplies as well as ...